Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
18.8%
% of SBIO's 90 holdings also in CNCR
25.0%
% of CNCR's 64 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
MERUS N.V. | 2.6% | 1.5% | 1.5% |
 |
IDEAYA BIOSCIENCES, INC. | 1.5% | 1.8% | 1.5% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED ADR | 1.3% | 1.6% | 1.3% |
|
ARCUS BIOSCIENCES, INC. | 0.8% | 1.6% | 0.8% |
|
NUVATION BIO INC CLASS A | 0.7% | 1.9% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to CNCR
 |
ALKERMES PLC | 4.3% |
|
AXSOME THERAPEUTICS, INC. | 4.2% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.4% |
|
PTC THERAPEUTICS INC | 3.3% |
|
AVIDITY BIOSCIENCES INC | 3.3% |
|
AKERO THERAPEUTICS, INC. | 3.0% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.8% |
|
CRINETICS PHARMACEUTICALS INC | 2.6% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.4% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 2.3% |
SBIO Underweight Relative to CNCR
|
SUMMIT THERAPEUTICS INC | -2.2% |
|
FATE THERAPEUTICS INC | -2.2% |
|
BLUEPRINT MEDICINES CORP. | -1.8% |
|
SUTRO BIOPHARMA, INC. | -1.8% |
|
EXELIXIS INC | -1.7% |
|
SCHRODINGER, INC. | -1.7% |
|
SYNDAX PHARMACEUTICALS INC | -1.7% |
 |
IMMATICS N.V. | -1.7% |
|
JANUX THERAPEUTICS, INC. | -1.7% |
|
REVOLUTION MEDICINES, INC. | -1.7% |